The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 6.00
Ask: 6.40
Change: -0.10 (-1.59%)
Spread: 0.40 (6.667%)
Open: 6.30
High: 6.30
Low: 6.20
Prev. Close: 6.30
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options

19 Sep 2017 16:43

RNS Number : 2057R
Kromek Group PLC
19 September 2017
 

19 September 2017

Kromek Group plc

("Kromek" or the "Company")

Exercise of Options

The Company notifies that, on 15 September 2017, Jerel Whittingham, a Director of the Company, exercised options over 250,000 ordinary shares of 1 pence each ("Ordinary Shares") in the capital of the Company, for an exercise price of 1.5 pence per share. Accordingly, application has been made for 250,000 new Ordinary Shares to be admitted to trading on AIM. The new Ordinary Shares will rank pari-passu with existing Ordinary Shares and it is expected that admission will occur on 25 September 2017.

Following this exercise of options, Mr Whittingham holds 364,890 Ordinary Shares, representing approximately 0.1 per cent of the Company's enlarged ordinary share capital. Following Admission, Kromek's issued share capital will comprise 260,395,618 Ordinary Shares, of which no Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 260,395,618 Ordinary Shares.

The above figure of 260,395,618 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries

Kromek Group plc

Arnab Basu, CEO

Derek Bulmer, CFO

+44 (0)1740 626 060

Cenkos Securities plc

Bobbie Hilliam (NOMAD)

Julian Morse (Sales)

+44 (0)20 7397 8900

Luther Pendragon Ltd

Harry Chathli, Claire Norbury, Alexis Gore

+44 (0)20 7618 9100

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jerel Whittingham

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 1 pence each

Identification code

GB00BD7V5D43

b)

Nature of the transaction

Exercise of options over Ordinary Shares of 1 pence each

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.5 pence

250,000

d)

 

Aggregated information

N/A

- Aggregated volume

- Price

e)

 

Date of the transaction

 

15 September 2017

f)

 

Place of the transaction

 

Outside trading venue

 

About Kromek Group plc

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEKLFFDKFZBBL
Date   Source Headline
2nd Aug 20227:00 amRNSFinal Results
2nd Aug 20227:00 amRNSKromek wins over $750k in new orders
7th Jul 20227:00 amRNSKromek enters agreement with Smiths Detection Inc.
25th May 20227:00 amRNSNew Nuclear Security order from US federal entity
16th May 202212:07 pmRNSDirector Share Purchase
16th May 20227:00 amRNSBusiness and Trading Update
16th May 20227:00 amRNSAppointment of Nominated Adviser and Broker
4th Apr 20227:00 amRNSNew £1.7m CBRN contract
18th Jan 20227:00 amRNSInterim Results
17th Dec 20214:41 pmRNSSecond Price Monitoring Extn
17th Dec 20214:35 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSNotice of Results
26th Oct 20217:00 amRNSKromek awarded contract by US based OEM customer
29th Sep 20213:14 pmRNSHolding(s) in Company
27th Sep 20211:47 pmRNSDirector Share Purchase
23rd Sep 20217:00 amRNSNuclear security contract from US federal entity
8th Sep 202111:09 amRNSResult of AGM
13th Aug 20213:48 pmRNSNotice of AGM and Publication of Annual Report
3rd Aug 202112:25 pmRNSHolding(s) in Company
15th Jul 202111:05 amRNSSecond Price Monitoring Extn
15th Jul 202111:00 amRNSPrice Monitoring Extension
14th Jul 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSNew Contracts
1st Jul 20217:00 amRNSNotice of Results
24th Jun 20214:41 pmRNSSecond Price Monitoring Extn
24th Jun 20214:36 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSKromek awarded new DARPA bio-threat contract
12th May 20212:50 pmRNSDirector Share Purchase
11th May 20217:00 amRNSBusiness and Trading Update
21st Apr 20214:32 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSKromek awarded Nuclear Detection contract
4th Mar 20211:32 pmRNSHolding(s) in Company
2nd Mar 20218:30 amRNSPDMR Dealings
1st Mar 20212:53 pmRNSResults of Placing, Open Offer and General Meeting
1st Mar 20217:00 amRNSNew Medical Screening and Nuclear Security orders
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:01 pmRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSPosting of Circular
12th Feb 202111:05 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
12th Feb 202110:30 amRNSPlacing and Open Offer to raise up to £13 million
4th Feb 20212:00 pmRNSIssue of Equity and Total Voting Rights
26th Jan 20215:15 pmRNSHolding(s) in Company
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
14th Jan 20219:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.